Clover Health Investments Corp. Cl A (CLOV) News
Filter CLOV News Items
CLOV News Results
| Date | Symbol | Company | Title | Start | End | Change | POWR Rating | ||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
CLOV News Highlights
-
404 Page not found Error: Page not found
The requested URL was not found on this server.
-
404 Page not found Error: Page not found
The requested URL was not found on this server.
-
404 Page not found Error: Page not found
The requested URL was not found on this server.
Latest CLOV News From Around the Web
Below are the latest news stories about CLOVER HEALTH INVESTMENTS CORP that investors may wish to consider to help them evaluate CLOV as an investment opportunity.
Clover Health Investments Corp. (CLOV): This Small-Cap Stock Is Poised To Outperform in 2025We recently compiled a list of the 15 Small-Cap Stocks Poised to Outperform in 2025. In this article, we are going to take a look at where Clover Health Investments Corp. (NASDAQ:CLOV) stands against the other small-cap stocks. Fifteen small-cap stocks—predominantly under the technology sector—are taking center stage this year, boasting triple- to quadruple-digit performance in […] |
Counterpart Health Deploys Counterpart Assistant with Leading Accountable Care OrganizationWILLMINGTON, Del., Jan. 07, 2025 (GLOBE NEWSWIRE) -- Counterpart Health, Inc. (“Counterpart”), an AI-powered physician enablement platform, today announced it has successfully deployed its Counterpart Assistant technology within Duke Connected Care (DCC), a recognized leader in accountable care and part of the prestigious Duke University Health System. Counterpart is a subsidiary of Clover Health Investments, Corp. (NASDAQ: CLOV) (“Clover Health”). Based in Durham, North Carolina, DCC is a physi |
US Growth Companies With High Insider OwnershipAs the U.S. stock market wraps up a strong year with some recent turbulence, major indices like the Nasdaq Composite and S&P 500 have still managed to post impressive gains, highlighting a period of robust growth despite recent setbacks. In this environment, identifying growth companies with high insider ownership can be particularly appealing to investors seeking alignment between management and shareholder interests, as these firms often demonstrate confidence in their long-term potential... |
December 2024's Promising US Penny StocksAs December 2024 unfolds, the U.S. stock market presents a mixed landscape, with the Dow Jones Industrial Average marking its fifth consecutive day of gains while the S&P 500 and Nasdaq Composite see minor declines. In this context, investors often turn to penny stocks—smaller or newer companies that can offer significant opportunities despite their somewhat outdated name. By focusing on those with strong financial foundations and potential for growth, investors can uncover hidden value in... |
Clover Health to Participate in Upcoming 43rd Annual J.P. Morgan Healthcare ConferenceJERSEY CITY, N.J., Dec. 17, 2024 (GLOBE NEWSWIRE) -- Remote-First Company -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover,” “Clover Health” or the “Company”), today announced that its Chief Executive Officer, Andrew Toy, will present at the 43rd Annual J.P. Morgan Healthcare Conference on Wednesday, January 15, 2025, at 4:30 p.m. Eastern Time. A live webcast and replay of the presentation and Q&A session will be accessible from Clover Health's investor relations website at https://in |
Cerus And 2 Other US Penny Stocks To WatchThe U.S. stock market recently experienced a stumble, particularly in technology shares, as investors assessed earnings reports and economic data amidst fluctuating interest rates and inflation expectations. In such a climate, the appeal of penny stocks remains significant for those seeking affordable entry points with potential growth prospects. While the term "penny stocks" may seem outdated, these typically smaller or newer companies can offer unique opportunities when supported by strong... |
Clover Health Investments Third Quarter 2024 Earnings: EPS Beats Expectations, Revenues LagClover Health Investments ( NASDAQ:CLOV ) Third Quarter 2024 Results Key Financial Results Revenue: US$331.0m (down 31... |
Clover Health Investments Corp (CLOV) Q3 2024 Earnings Call Highlights: Strong Financial ...Clover Health Investments Corp (CLOV) reports improved profitability and reaffirms full-year guidance amid strategic investments and technology-driven advancements. |
Clover Health Reports Strong Third Quarter 2024 Financial Results; Highlights Differentiated Market Opportunity to Grow MembershipDelivers 9% Total Revenue growth year-to-date compared to prior year period Company improves 2024 year-to-date GAAP Net Loss from Continuing Operations by $117.4 million year-over-year and year-to-date Adjusted EBITDA by $87.2 million year-over-year Increases Full-Year 2024 guidance midpoint to target updated range of Adjusted EBITDA profitability of $55 million - $65 million, strongly positioning the Company to invest in membership growth opportunity for 2025 FRANKLIN, Tenn., Nov. 06, 2024 (GLO |
Top US Penny Stocks To Watch In October 2024As investors navigate a landscape marked by mixed economic signals and fluctuating stock indices, penny stocks continue to capture attention for their unique potential. Although the term 'penny stock' may sound outdated, it remains relevant in identifying smaller or newer companies that could offer substantial growth opportunities. By focusing on those with solid financial foundations, investors can uncover promising prospects within this intriguing segment of the market. |